Simplex Trading
ELDN icon

Simplex Trading’s Eledon Pharmaceuticals ELDN Stock Holding History

Simplex Trading’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$349K Buy
+88,597
New +$322K ﹤0.01% 4043
2025
Q4 		– Sell
-15,997
Closed -$38K – 8910
2025
Q3 		$41K Buy
15,997
+7,724
+93% +$22.6K ﹤0.01% 6647
2025
Q2 		$22K Sell
8,273
-1,718
-17% -$5.16K ﹤0.01% 6682
2025
Q1 		$33K Sell
9,991
-446
-4% -$1.83K ﹤0.01% 6156
2024
Q4 		$43K Buy
+10,437
New +$41.1K ﹤0.01% 6023
2024
Q1 		– Sell
-3,223
Closed -$5.75K – 9080
2023
Q4 		$5K Sell
3,223
-400
-11% -$556 ﹤0.01% 7843
2023
Q3 		$4K Buy
3,623
+3,403
+1,547% +$4.54K ﹤0.01% 7749
2023
Q2 		$0 Buy
220
+151
+219% +$315 ﹤0.01% 9196
2023
Q1 		$0 Buy
+69
New +$185 ﹤0.01% 9272
2022
Q3 		– Sell
-287
Closed -$914 – 10117
2022
Q2 		$0 Sell
287
-1,384
-83% -$4.22K ﹤0.01% 10192
2022
Q1 		$6K Sell
1,671
-1,046
-38% -$4.05K ﹤0.01% 9271
2021
Q4 		$11K Buy
2,717
+2,682
+7,663% +$13.6K ﹤0.01% 8928
2021
Q3 		$0 Hold
35
– – ﹤0.01% 9788
2021
Q2 		$0 Buy
+35
New +$330 ﹤0.01% 10168
2017
Q1 		– Hold
0
– – – 6287
2016
Q4 		– Hold
0
– – – 5983

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

Simplex Trading's ELDN Position: Q2 2026 in Review

Simplex Trading opened a new position in Eledon Pharmaceuticals (ELDN) in Q2 2026: 88,597 shares worth $349K. The stake represents ﹤0.01% of the portfolio and ranks #4043 among its holdings. This is a return to the name: Simplex Trading previously reported a position in ELDN as recently as Q3 2025.

Simplex Trading first reported a position in ELDN in Q2 2021 and has held it in 14 quarters since. 161 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • Simplex Trading held 88,597 shares of Eledon Pharmaceuticals worth $349K as of Q2 2026.
  • Eledon Pharmaceuticals was a new Simplex Trading position in Q2 2026.
  • Eledon Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #4043 holding.
  • Simplex Trading first reported a position in Eledon Pharmaceuticals in Q2 2021 and has held it in 14 quarters since.
  • 161 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.